OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fresh evidence for major brain gangliosides as a target for the treatment of Alzheimer's disease
Marina Dukhinova, Tatyana Veremeyko, Amanda W. Y. Yung, et al.
Neurobiology of Aging (2019) Vol. 77, pp. 128-143
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications
Simonetta Sipione, John Monyror, Danny Galleguillos, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 223

Ganglioside GM1 and the Central Nervous System
Zhongwu Guo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9558-9558
Open Access | Times Cited: 29

Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
Jacques Fantini, Henri Chahinian, Nouara Yahi
Protein Science (2020) Vol. 29, Iss. 8, pp. 1748-1759
Open Access | Times Cited: 53

Spatial Lipidomics Reveals Region and Long Chain Base Specific Accumulations of Monosialogangliosides in Amyloid Plaques in Familial Alzheimer’s Disease Mice (5xFAD) Brain
Ibrahim Kaya, Eva Jennische, Johan Dunevall, et al.
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 1, pp. 14-24
Closed Access | Times Cited: 50

Glycosylation changes in inflammatory diseases
Sophie Groux‐Degroote, Sumeyye Cavdarli, Kenji Uchimura, et al.
Advances in protein chemistry and structural biology (2019), pp. 111-156
Open Access | Times Cited: 45

Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
Orhan Kerim İnci, Hande Basırlı, Melike Can, et al.
Journal of Lipids (2024) Vol. 2024, pp. 1-10
Open Access | Times Cited: 5

Platelets promote epileptic seizures by modulating brain serotonin level, enhancing neuronal electric activity, and contributing to neuroinflammation and oxidative stress
Ekaterina Kopeikina, Marina Dukhinova, Amanda W. Y. Yung, et al.
Progress in Neurobiology (2020) Vol. 188, pp. 101783-101783
Closed Access | Times Cited: 38

The Role of Lipid Environment in Ganglioside GM1-Induced Amyloid β Aggregation
Vladimı́r Rudajev, Jiřı́ Novotný
Membranes (2020) Vol. 10, Iss. 9, pp. 226-226
Open Access | Times Cited: 35

The Role of Neuronal Factors in the Epigenetic Reprogramming of Microglia in the Normal and Diseased Central Nervous System
Tatyana Veremeyko, Amanda W. Y. Yung, Marina Dukhinova, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 30

The significance of sialylation on the pathogenesis of Alzheimer’s disease
Kangkang Yang, Zhaofei Yang, Xiaofeng Chen, et al.
Brain Research Bulletin (2021) Vol. 173, pp. 116-123
Closed Access | Times Cited: 26

Integrative Single-Plaque Analysis Reveals Signature Aβ and Lipid Profiles in the Alzheimer’s Brain
Thomas Enzlein, Tammaryn Lashley, Denis Abu Sammour, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 24, pp. 9799-9807
Open Access | Times Cited: 3

Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry
Mirela Sârbu, Raluca Ică, Alina D. Zamfir
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 693-693
Open Access | Times Cited: 14

Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer’s disease and vascular dementia
Xin Ying Chua, Federico Torta, Joyce R. Chong, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8

ASD-like behaviors, a dysregulated inflammatory response and decreased expression of PLP1 characterize mice deficient for sialyltransferase ST3GAL5
Tatyana Strekalova, Evgeniy Svirin, Ekaterina Veniaminova, et al.
Brain Behavior & Immunity - Health (2021) Vol. 16, pp. 100306-100306
Open Access | Times Cited: 16

Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer’s disease
James C. Dodge, Thomas J. Tamsett, Christopher M. Treleaven, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 11

Sialic acid: an attractive biomarker with promising biomedical applications
Aida Doostkam, Leila Malekmakan, Alireza Hosseinpour, et al.
Asian Biomedicine (2022) Vol. 16, Iss. 4, pp. 153-167
Open Access | Times Cited: 10

Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis
Antero Salminen, Kai Kaarniranta, Anu Kauppinen
Neurochemistry International (2021) Vol. 150, pp. 105186-105186
Open Access | Times Cited: 14

Gene Therapy Strategy for Alzheimer’s and Parkinson’s Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells
Assou El‐Battari, Léa Rodriguez, Henri Chahinian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11550-11550
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top